Company Filing History:
Years Active: 1997-2000
Title: The Innovations of Daniel L Kisner
Introduction
Daniel L Kisner is a notable inventor based in Cardiff, CA (US). He has made significant contributions to the field of antiviral treatments, particularly focusing on cytomegalovirus (CMV) infections. With a total of 3 patents to his name, Kisner's work has the potential to impact the medical community significantly.
Latest Patents
Kisner's latest patents include innovative compositions and methods for the treatment of CMV infections. One of his notable inventions is a composition that utilizes antisense oligonucleotides as effective antiviral agents. These oligonucleotides are designed with at least one 2'-methoxyethoxy modification and may also be chimeric oligonucleotides. Another significant patent involves an antisense composition targeted at the IE2 gene of CMV, which, when combined with a pharmaceutically acceptable carrier, aims to halt the progression of CMV retinitis.
Career Highlights
Kisner has been associated with Isis Pharmaceuticals, Inc., where he has been able to apply his expertise in developing antiviral therapies. His work has been instrumental in advancing the understanding and treatment of viral infections, particularly those caused by CMV.
Collaborations
Throughout his career, Kisner has collaborated with esteemed colleagues such as Kenneth G Draper and Sharon K Chapman. These collaborations have further enriched his research and development efforts in the field of antiviral treatments.
Conclusion
Daniel L Kisner's contributions to antiviral research, particularly in the treatment of CMV infections, highlight his innovative spirit and dedication to improving healthcare outcomes. His patents reflect a commitment to advancing medical science and providing effective solutions for viral infections.